title: Stereoselective binding of chiral anti-diabetic drug nateglinide to plasma proteins.
abstract: The binding of nateglinide (NA) enantiomers with human plasma (HP), human serum albumin (HSA) and bovine serum albumin (BSA) was investigated. The protein binding was studied over a drug concentration range of 5-100 μM at a protein concentration of 600 μM. Unbound drug concentrations were determined by direct chiral liquid chromatography using chiralcel OJ-RH column. At therapeutic drug concentrations, the protein binding of each enantiomer was >98%. The results showed that the binding of NA enantiomers was stereoselective, mutually competitive and non-linear. The binding characteristics were, however, opposite for the two most important plasma binding proteins. Opposite stereo-selectivity was observed between BSA and HSA while stereo-selectivity was identical between HSA and HP. Scatchard analysis was used to illustrate the different binding affinities of NA enantiomers to BSA, HSA and HP. The interaction between enantiomers observed in HP and serum albumins was confirmed as a competitive type interaction at the high affinity site. Scatchard analysis was used to illustrate the different binding affinities of NA enantiomers to BSA, HSA and HP.
authors: Department of Pharmaceutical Chemistry, Friedrich Schiller University, Jena, Germany. maddi_cnu@yahoo.co.in
authors: Srinivas
authors: S
authors: Maddi
authors: Gerhard
authors: G
authors: Scriba
authors: Madhusudan Rao
authors: MR
authors: Yamsani
mesh_terms: D001798:Blood Proteins / Q000378:metabolism; D003510:Cyclohexanes / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism*; D000077715:Nateglinide; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000378:metabolism; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism; D013237:Stereoisomerism
chemical_list: D001798:Blood Proteins; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D012709:Serum Albumin; D000077715:Nateglinide; D010649:Phenylalanine